NEW YORK TIMES CO
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/26/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.8B | $2.6B | $2.4B | $2.3B | $2.1B |
| Research and development | $264.3M | $248.2M | $228.8M | $204.2M | $160.9M |
| Operating income | $431.6M | $351.1M | $276.3M | $202.0M | $268.0M |
| Pretax income | $451.3M | $383.4M | $302.6M | $236.0M | $290.5M |
| Income tax expense | $107.3M | $89.6M | $69.8M | $62.1M | $70.5M |
| Net income | $344.0M | $293.8M | $232.4M | $173.9M | $220.0M |
| Balance Sheet | |||||
| Cash and equivalents | $255.4M | $199.4M | $289.5M | $221.4M | $320.0M |
| Current assets | $1.0B | $936.3M | $781.7M | $655.7M | $952.7M |
| Total assets | $3.0B | $2.8B | $2.7B | $2.5B | $2.6B |
| Current liabilities | $666.7M | $613.5M | $611.6M | $571.2M | $559.2M |
| Stockholders' equity | $2.0B | $1.9B | $1.8B | $1.6B | $1.5B |
| Cash Flow Statement | |||||
| Cash from operations | $584.5M | $410.5M | $360.6M | $150.7M | $269.1M |
| Depreciation and amortization | $85.0M | $82.9M | $86.1M | $82.7M | $57.5M |
| Stock-based compensation | $74.2M | $67.5M | $54.8M | $35.3M | $22.2M |
| Capital expenditure | $34.0M | $29.2M | $22.7M | $37.0M | $34.6M |
| Free cash flow | $550.5M | $381.3M | $337.9M | $113.7M | $234.5M |
| Dividends paid | $110.4M | $82.9M | $69.5M | $56.8M | $45.3M |
| Share repurchases | $165.3M | $85.0M | $44.6M | $105.1M | $0 |
| Impairments | $2.9M | $0 | $15.2M | $4.1M | $0 |
Shares outstanding 161.9M · Free float 83.8%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.
Recent filings
- May 6, 2026 10-Q
- May 6, 2026 8-K
- April 23, 2026 8-K
- February 27, 2026 10-K
- February 4, 2026 8-K
- January 21, 2026 8-K
- November 5, 2025 10-Q
- November 5, 2025 8-K